Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Lysine-specific histone demethylase 1a regulates nephron development and long-term transcriptional programming
Nicola Wanner, Julia Keller, Nastassia Liaukouskaya, Geoffroy Andrieux, Sandra D. Laufer, Manuel Rogg, Tillmann Bork, Wei Liang, Fabian Braun, Fabian Haas, Milagros N. Wong, Victor G. Puelles, Sydney E. Gies, Charlotte Meyer, Melanie Boerries, Martin Helmstädter, Oliver Kretz, Iris Hild, Eric Metzger, Roland Schüle, Wibke Bechtel-Walz, Tobias B. Huber
Nicola Wanner, Julia Keller, Nastassia Liaukouskaya, Geoffroy Andrieux, Sandra D. Laufer, Manuel Rogg, Tillmann Bork, Wei Liang, Fabian Braun, Fabian Haas, Milagros N. Wong, Victor G. Puelles, Sydney E. Gies, Charlotte Meyer, Melanie Boerries, Martin Helmstädter, Oliver Kretz, Iris Hild, Eric Metzger, Roland Schüle, Wibke Bechtel-Walz, Tobias B. Huber
View: Text | PDF
Research Article Development Nephrology

Lysine-specific histone demethylase 1a regulates nephron development and long-term transcriptional programming

  • Text
  • PDF
Abstract

Low nephron endowment constitutes a risk factor for hypertension and renal disease. Epigenetic regulation is crucial for nephron progenitor cell differentiation, affecting nephron number and renal function. The role of many epigenetic modulators, such as Lysine-specific histone demethylase 1a (LSD1 or KDM1A), remains unclear. We used Kdm1a-KO mice to demonstrate that Kdm1a depletion in nephron progenitor cells results in reduced kidney size in neonates and led to glomerulosclerosis, proteinuria, and renal cysts in adults. Notably, Kdm1a deletion in podocytes or tubular cells did not replicate these effects. CRISPR/Cas9-mediated KDM1A deletion in human kidney organoids caused cyst formation and altered gene expression, with snRNA-seq revealing downregulation of podocyte genes and upregulation of metabolic genes. The presence of noncoding RNAs indicated roles in cell proliferation. Our study reveals the critical role of Kdm1a function in nephron development and highlights its affect on transcriptional programming for long-term renal function and susceptibility to cyst formation.

Authors

Nicola Wanner, Julia Keller, Nastassia Liaukouskaya, Geoffroy Andrieux, Sandra D. Laufer, Manuel Rogg, Tillmann Bork, Wei Liang, Fabian Braun, Fabian Haas, Milagros N. Wong, Victor G. Puelles, Sydney E. Gies, Charlotte Meyer, Melanie Boerries, Martin Helmstädter, Oliver Kretz, Iris Hild, Eric Metzger, Roland Schüle, Wibke Bechtel-Walz, Tobias B. Huber

×

Figure 5

Specific loss of KDM1A in podocytes or proximal tubular cells does not impair kidney function.

Options: View larger image (or click on image) Download as PowerPoint
Specific loss of KDM1A in podocytes or proximal tubular cells does not i...
(A) Schematic of the conditional NPHS2Cre Lsd1fl/fl mouse model. (B) Antibody staining shows KDM1A in the Nephrin-positive podocytes in the WT, but not in Pod.Cre KO animals at 5 weeks. Scale bar: 10 μm. (C) Histological analysis (PAS) of WT and KO kidneys show no structural changes upon conditional Kdm1a ablation in podocytes. Scale bars: 50 μm (left) and 20 μm (right). (D and E) Albumin/creatinine ratio in the urine and urea levels in the blood serum at < 25 weeks, < 25 weeks, and < 1 year show no differences in the WT and podocyte KO animals. (F) Schematic of the Pax8rtTA tetOCre Kdm1afl/fl mouse model. (G) Antibody staining shows KDM1A in the Megalin-positive proximal tubules in the WT, but not in Pax8.rtTA tetOCre KO animals. Scale bar: 20 μm. (H) Histological analysis (PAS) of WT and KO kidney at p63 show no structural changes upon inducible Kdm1a ablation in proximal tubules. Scale bar: 200 μm. (I and J) Body weight and kidney weight of Pax8.rtTA tetOCre KO animals at p21 and p63 show no difference to WT animals. Unpaired 2-tailed Student’s t test was used.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts